News

Impact investors have an opportunity to make the AI industry safer and reap sizeable returns in the process, panellists tell the Impact Investor Global Summit.

Harper Court Ventures Fund I will target pre-seed and seed-stage companies in sectors that include AI, quantum computing, life sciences and energy.

LPs in Zeal Capital's Fund II include Citi Impact Fund, M&T Bank, MassMutual, Wells Fargo, Zaffre Investments and Spelman College, as well as VCs Scott Sandell and Jason Green.

Mat Powley, a partner on the private capital team, talks about the $28bn UK multifamily office’s approach to new and venture GPs for its flagship fund of funds.

LPs include French corporates Groupe ADP and Valeo, and Spanish government investment organization Institut Català de Finances, PEI reported.

The fund’s strategic and impact-oriented LPs include big pharma names such as Pfizer, Bristol Myers Squibb, AARP and Alzheimer’s Research UK, which are excited by improved scientific understanding of dementia that promise to increase clinical trial successes.

The fund, which is targeting €125m, will focus on early-stage start-ups across Europe operating in sectors such as cybersecurity, information superiority, robotics, AI, autonomous systems and space technology.

Greycroft, Baroda Ventures and Mercato Partners posted significant gains in the MNTN offering, while Insight Venture Partners, Atomico and 11.2 Capital are among the big winners for Hinge.

The firm has invested in Coupang, Carvana, Databricks, Flipkart, Discord, Stripe and Wiz.

The fund’s founding LP is HSB.